Ещё дополнительная информация связанная с озонотерапии.
Хочу сразу отметить, что новые, дополнительные данные по ОТ, привожу отнюдь не для агитации присутствующих врачей. Как правило, у врачей появляется интерес к этой терапии только после общения с коллегами, её практикующими.
Но на форуме, не раз раздавались бурные продолжительные аплодисменты, после «наездов» на меня типа: «такую шарлатанскую ( как вариант, фашистскую) терапию могут втюривать только в такой африканской стране, как Россия».
«По Вам г-н Зайцев давно тюрьма плачет, и т.п.». Вот я и стараюсь, чтобы мои оппоненты прикинули: нельзя ли для меня условным сроком ограничится?
Сначала. Ещё одно подтверждение, что даже в США озонотерапию используют в клиниках для лечения различных заболеваний. И НЕ САЖАЮТ!
OZ-PO-050: THE USE OF OZONE IN COLONIC THERAPY.
Dr. Dirk Yow.
Tahoma Clinic, Kent, Washington, USA.
This paper reviews the outcome of a combination of ozone therapy with colonics administered (herbal enemas) through the methods passed on in the naturopathic tradition in the USA, in the last three years. The relationship of ozone and its oxidative properties along side an ability to enhance the colonyc hydrotherapy responses in a variety of factors related to various symptoms and ailments will be discuss. 250 patients (men and women with an age range between 15 and 85) were received into therapy in the Colon Therapy Department by self referral, after an evaluation of a health questionnaire performed by the medical director, or by referral from a physician. Of the patients treated the major indications were: gastro-intestinal complaints, cutaneous conditions, malaise and chronic fatigue, arthritic conditions and others. It is postulated that the methods of achieving benefit accrue through: 1.Drainage and treatment of infected tissues, 2. Breaking the formation of vicious cycles in auto-intoxification, 3. Building up immunity against infection, 4.Treating specific infectious organisms, 5. Defining secondary foci and primary foci. The clinical benefit ratio for this form of therapy, as an adjunct to other modalities, is favorable.
Теперь к вопросу, который мне уже задавался. ОТ в онкологии. Хотя, как я уже сообщал, исследований ОТ в этой области пока недостаточно и они разрознены для каких-либо окончательных выводов.
OZ-PO-039: TUMOR pO2 MODIFICATION BY OZONETHERAPY.
B. Clavo (a), M. Lloret (a), L. López (a), G. Suárez (a), M. Santana (a), J.L. Pérez (b), V. Rodríguez (c), D. Macías (b), M.A. Hernández (a), R. Martín-Oliva (b), G. Rovira (d) and M Günderoth (e).
(a) Pino Hospital: Radiation Oncology-Research Unit, Las Palmas, (b) Pino Hospital: Medical Physics Unit., Las Palmas, (c) La Paterna Center, Las Palmas, (d) Quiron Clinic, Barcelona, Spain, (e) Helzel Medical Systems,Germany.
Hypoxic tumor cells are 2.5 - 3 times more resistant to radiotherapy, with higher metastatic potential than normoxic cells. Tumor hypoxia is an independent prognostic factor in head and neck and uterine cervix tumors. As has been demonstrated by the meta-analysis of Overgaard and the multicenter clinical trials, hypoxia modification prior to or during the course of radiotherapy can increase the effectiveness of treatment and improve prognosis. Ozonetherapy (O3T) has been used to treat ischemic disorders. This study evaluated the effect of O3T on tumor pO2 in humans. We study 16 patients with advanced or relapsed cancer: Male:Female 13 : 3, between 50 – 91 years old. O3T was carried out by autohemotransfusion 3 alternating days over one week. Tumour pO2 was measured by a polarographic probe system, four times. There were 150-200 determinations every time. During O3T there was significant increase (Friedman test: p = 0.013) in tumor oxygenation and decrease of hypoxic fractions, with prolonged effect. There was inverse and significant correlation between individual "Increase Factor" and "initial pO2 value": higher increase oxygenation in those initially worse oxygenated tumors (Spearman rho = - 0.885, p < 0.001. These findings support that ozone therapy could be a useful adjuvant in treatment of hypoxic tumors.